Glenmark Pharmaceuticals has become the first Pharmaceutical Company to launch Thiazolidinedione Lobeglitazone (Lobeglitazone) in India for the treatment of type 2 diabetes in adults. Marketed under the brand name LOBG; it contains Lobeglitazone (0.5 mg) and to be taken once daily under prescription to improve glycemic control in adult diabetic patients. Indians have a high … Read more
Glenmark Pharmaceuticals has launched India’s first topical Minocycline 4% Gel for the treatment of moderate to severe acne, under the brand name Minym. This is a potent antibacterial gel which exerts a strong anti-inflammatory action It also offers the lowest MIC90 (minimum Inhibitory Concentration at which it stops/prevents visible growth of 90% of isolates of … Read more
Glenmark Pharma is currently trading at Rs. 454.35, up by 10.45 points or 2.35% from its previous closing of Rs. 443.90 on the BSE. The scrip opened at Rs. 445.00 and has touched a high and low of Rs. 457.85 and Rs. 445.00 respectively. So far 42623 shares were traded on the counter. The BSE … Read more
Glenmark Pharmaceuticals has reported results for third quarter ended December 31, 2021. The company has reported a rise of 24% in its net profit at Rs 548.52 crore for the quarter under review as compared to Rs 442.33 crore for the same quarter in the previous year. Total income of the company increased by 9.55% … Read more
Glenmark Pharmaceuticals’ subsidiary — Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (USFDA) for Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg, the generic version of Ziac Tablets, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg, … Read more
Glenmark Pharmaceuticals is currently trading at Rs. 516.85, up by 0.85 points or 0.16% from its previous closing of Rs. 516.00 on the BSE. Glenmark Pharmaceuticals The scrip opened at Rs. 513.50 and has touched a high and low of Rs. 519.10 and Rs. 505.00 respectively. So far 40875 shares were traded on the counter. … Read more
Glenmark Pharmaceuticals’ subsidiary — Glenmark Pharmaceuticals Inc., USA (Glenmark) has received tentative approval by United States Food & Drug Administration (USFDA) for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe, the generic version of Lexiscan Injection, 0.4 mg/5 mL (0.08 mg/mL), of Astellas US, Inc. Sales data for the 12 month period ending … Read more
